ACADIA Pharmaceuticals In...

NASDAQ: ACAD · Real-Time Price · USD
25.30
0.77 (3.14%)
At close: Aug 15, 2025, 3:59 PM
25.33
0.12%
After-hours: Aug 15, 2025, 04:04 PM EDT

ACADIA Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
222.16M 228.88M 226.45M 128.51M 30.57M -1.71M -61.29M -148.81M -110.81M -145.94M -215.97M -217.34M -204.62M -214.48M -167.87M -191.54M -261.74M -260.01M
Depreciation & Amortization
2.4M 6.13M 8.7M 5.13M 11.46M 10.65M 5.55M 4.4M 3.19M 1.94M 2.03M 2.07M 2.55M 2.96M 3.34M 3.65M 3.37M 3.16M
Stock-Based Compensation
62.33M 63.68M 67.05M 74.62M 67M 66.47M 66.42M 62.81M 62.59M 67.94M 68.2M 66.67M 63.9M 65.39M 63.62M 71.93M 77.76M 75.26M
Other Working Capital
64.61M 76.85M 76.78M 84.19M 76.33M 72.06M 80.57M 51.23M 33.08M 27.9M 27.54M 29.36M 24.27M 11.49M -2.88M 664K 7.68M 5.03M
Other Non-Cash Items
-159.94M -117.38M -78.66M 107.84M 176.15M 103.99M 60.78M 19.97M -31.81M -14.84M -8.12M -5.47M -73K -361K 75K 1.44M 46.34M 45.99M
Deferred Income Tax
n/a n/a n/a -38.95M -89.02M -72.89M -72.89M -33.95M 16.13M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
60.95M 25.4M 30.31M 21.71M -19.49M -4.4M 18.13M 3.03M 24.57M 33.41M 37.99M 38.93M 8.6M 4.64M -24.82M -15.51M -1.48M -11.71M
Operating Cash Flow
187.91M 148.96M 157.72M 202.73M 80.53M 63.71M 16.7M -92.54M -34.31M -55.64M -114.03M -113.3M -129.64M -141.84M -125.66M -130.03M -135.76M -147.31M
Capital Expenditures
-820K -99.36M -523K -70K -50K -40.05M -40.05M -40.05M -40M n/a n/a -1K -1K -46K -1.12M -3.12M -4.84M -7.73M
Cash Acquisitions
n/a n/a n/a n/a 50K 40.05M 40.05M 40.05M 40M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-617.65M -580.95M -505.1M -473.44M -359.16M -383.25M -369.99M -359.43M -466.47M -430.07M -363.17M -308.58M -415.65M -364.93M -492.8M -692.95M -441.62M -367M
Sales Maturities Of Investments
443.14M 393.25M 328.56M 320.48M 322.74M 248.74M 442.03M 414.07M 502.4M 564.48M 436.42M 471.12M 406.43M 394.35M 422.82M 436.46M 496.17M 568.51M
Other Investing Acitivies
47.68M 90.32M 76.28M -70.58M -70.63M -54.44M 152.12M 134.72M 150.21M 134.41M 73.24M 162.54M -9.22M 29.41M -69.98M -256.49M 54.55M 201.51M
Investing Cash Flow
-127.65M -140.55M -30.54M -153.03M -36.47M -174.56M 32M 14.6M -4.07M 134.41M 73.24M 162.54M -9.22M 29.37M -71.1M -259.61M 49.71M 193.78M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
20.03M 7.64M 6.84M 10.31M 22.79M 24.71M 25.13M 21.31M 8.85M 7.2M 8.2M 10.95M 11.73M 12.9M 18.16M 31.92M 42.57M 84.97M
Net Cash Flow
85.97M 21.72M 139.7M 65.73M 66.84M -86.15M 73.81M -56.65M -29.54M 85.97M -32.59M 60.2M -127.12M -99.57M -178.59M -357.71M -43.48M 131.43M
Free Cash Flow
187.09M 49.6M 157.2M 202.66M 80.48M 23.66M -23.35M -132.59M -74.31M -55.64M -114.03M -113.3M -129.64M -141.89M -126.78M -133.15M -140.6M -155.04M